David Genoux
About David Genoux
David Genoux is a Senior Manager in Pharmacovigilance Quality Risk Management at Bristol Myers Squibb in Boudry, Switzerland, with extensive experience in quality assurance, risk management, and project management across various pharmaceutical and biotechnology companies.
Title and Current Position
David Genoux is the Senior Manager of Pharmacovigilance Quality Risk Management at Bristol Myers Squibb. He is based in Boudry, Neuchâtel, Switzerland. His role entails leading the implementation of Quality Risk Management processes specifically tailored for Pharmacovigilance and Patient Safety Systems.
Previous Work Experience
David Genoux has accumulated extensive experience across various organizations. He worked at Merck Group as Associate Manager in Risk Management, Post-Market Surveillance, and Clinical Evaluation from 2017 to 2021. Prior to that, he was a Quality Assurance Specialist at Bio-Rad Laboratories for 11 months in 2016-2017. He served as a Product Development Quality Engineer and Risk Manager at Johnson & Johnson from 2014 to 2016. He also had shorter stints at Merck Group, Baxter International Inc., and Amazentis SA in various quality and project management roles.
Educational Background and Certifications
David Genoux holds a Doctor of Philosophy (Ph.D.) in Life Sciences from ETH Zurich. He also studied Biotechnology, earning an Engineer degree from ENSTBB Bordeaux INP, and a Master of Science and Technology in Biological & Biochemical Engineering from Université Paris-Est Créteil (UPEC). He has certifications from the PMI Project Management Institute (CAPM PMP) and is certified in Operational Excellence with expertise in Lean and Six Sigma tools.
Skills and Areas of Expertise
David Genoux has expertise in using Quality Risk Management tools and systems such as Trackwise 8, SAP, Minitab, and Oracle Agile. He is proficient in managing document control systems and writing Standard Operating Procedures (SOPs). He has a comprehensive understanding of GMP, Swissmedic, FDA 21 CFR 210&211, ICH Q9 & Q10, and Eudralex Vol. 4 regulations. His skills extend to conducting internal and external audits, managing deviations, CAPA, and change control, and handling Clinical Evaluation Reports and Post Market Surveillance activities.
Experience in Research and Development
David Genoux has a notable background in research and development. He has managed pre-clinical studies and R&D projects at institutions like EPFL, The University of Auckland, Collège de France, and ETH Zurich. His expertise spans biotechnology, including upstream and downstream processing, biochemistry, microbiology, and chemistry. His roles have often involved overseeing R&D initiatives and project management in various scientific domains.